The ACI is a new industry body which is committed to nurturing a safe, legal and well regulated CBD market in the UK.

Our vision is to create an innovative, sustainable sector that meets the highest standards in product quality, consumer satisfaction and environmental stewardship.

COVID-19 Business Support Resources.

For information on FSA CBD regulations see our FAQ.

Share our commitment and vision?
Find out more about becoming a member of the ACI here

The ACI is committed to the development of a legal, safe and regulated CBD market. A fundamental aspect of achieving this is ensuring that consumers have confidence in our products.

The key benchmarks for this are how many people express confidence in the efficacy of our products, and how many would be more likely to do so if there was better regulation.

In that context, the findings from our YouGov survey* are truly illuminating: they are a vindication of why we set up the ACI, launched the ACI charter and committed our members to working towards full novel foods authorisation and standardisation of analytical testing methodologies.

* Methodology: This survey has been conducted using an online interview administered to members of the YouGov Plc UK panel of 800,000+ individuals who have agreed to take part in surveys. Read More

Want to know more about our regulatory approach?

The ACI partnered with The Cannabis Conversation to produce this panel discussion and explainer with Dr Parveen Bhatarah the CMC/ACI Regulatory Lead, Dr Sarah Gaunt from Global Regulatory Services our regulation partners and Shomi Malik our Development Director.

12 Mar, 2020

Statement from ACI founder Steve Moore

It has been quite a start to 2020 across our sector, with significant regulatory developments in both the medicinal cannabis and the CBD wellness space.

However, right now we all have to adapt to a new world and the unprecedented challenge a global pandemic presents us all.

11 Mar, 2020

New Poll Finds Overwhelming Public Support For FSA CBD Regulation

A new YouGov poll commissioned by The Association for the Cannabinoid Industry demonstrates overwhelming support for recent FSA guidance concerning CBD

19 Feb, 2020

FAQ for CBD Consumers, Retailers, Manufacturers and Health Care Professionals

Following the FSA’s recent announcement, relating to CBD regulation and precautionary health advice, ACI’s experts have compiled the following FAQ covering the questions consumers, retailers, manufacturers or health care professionals may have concerning CBD.

Media enquiries +44 (0)7870515025

Request membership information

Fill in the form and our team will get back to you to discuss our membership options.
Please read the Quality Charter before submitting your details.